Publications by ONCCC-R-NET Leaders 

  1. Nates JL, Morales F, Cardenas YR, Morales F, Quintero A. Manual de emergencias oncológicas - Fundamentos de manejo, 1. Distribuna, 300, 2020.
  2. Nates JL, Price K. Oncologic Critical Care. First English Edition. Springer Nature: Switzerland, 2019. PMID: 978-3-319-74589-3. 
  3. JL Nates, I Pujol, YR Cardenas, A Quintero. Ed(s) Joseph L. Nates, Ignacio Pujol, Yenny Rocio Cardenas Bolivar, Agamenon Quintero. Oncologic Critical Care. Spanish Edition, 2017. PMID: 978-958-8815-68-4.​
  4. Critical Care Management of Toxicities Associated With Targeted Agents and Immunotherapies for Cancer.
    Gutierrez C, McEvoy C, Munshi L, Stephens RS, Detsky ME, Nates JL, Pastores SM.
    Crit Care Med. 2020 Jan;48(1):10-21. doi: 10.1097/CCM.0000000000004087.
    PMID: 31725440
  5. Renal Replacement Therapy in Patients With Stage IV Cancer Admitted to the Intensive Care Unit With Acute Kidney Injury at a Comprehensive Cancer Center Was Not Associated With Survival. Abudayyeh A, Song J, Abdelrahim M, Dahbour I, Page VD, Zhou S, Shen C, Zhao B, Pai RN, Amaram-Davila J, Manzano JG, George MC, Yennu S, Mandayam SA, Nates JL, Moss AH.Am J Hosp Palliat Care. 2020 Jan 27:1049909120902115. doi: 10.1177/1049909120902115. [Epub ahead of print]PMID: 31986903
  6. Changes in End-of-Life Practices in European Intensive Care Units From 1999 to 2016. Sprung CL, Ricou B, Hartog CS, Maia P, Mentzelopoulos SD, Weiss M, Levin PD, Galarza L, de la Guardia V, Schefold JC, Baras M, Joynt GM, Bülow HH, Nakos G, Cerny V, Marsch S, Girbes AR, Ingels C, Miskolci O, Ledoux D, Mullick S, Bocci MG, Gjedsted J, Estébanez B, Nates JL, Lesieur O, Sreedharan R, Giannini AM, Fuciños LC, Danbury CM, Michalsen A, Soliman IW, Estella A, Avidan A. JAMA. 2019 Oct 2:1-12. doi: 10.1001/jama.2019.14608. [Epub ahead of print] Erratum in: JAMA. 2019 Nov 5;322(17):1718. PMID: 31577037
  7. Clinical Practice Guidelines and Consensus Statements About Pain Management in Critically Ill End-of-Life Patients: A Systematic Review. 
    Durán-Crane A, Laserna A, López-Olivo MA, Cuenca JA, Díaz DP, Cardenas YR, Urso C, O'Connell K, Azimpoor K, Fowler C, Price KJ, Sprung CL, Nates JL. 
    Crit Care Med. 2019 Nov;47(11):1619-1626. doi: 10.1097/CCM.0000000000003975.
    PMID: 31517694.
  8. Evidence-based clinical practice guidelines for the management of sedoanalgesia and delirium in critically ill adult patients. Celis-Rodríguez E, Díaz Cortés JC, Cárdenas Bolívar YR, Carrizosa González JA, Pinilla DI, Ferrer Záccaro LE, Birchenall C, Caballero López J, Argüello BM, Castillo Abrego G, Castorena Arellano G, Dueñas Castell C, Jáuregui Solórzano JM, Leal R, Pardo Oviedo JM, Arroyo M, Raffán-Sanabria F, Raimondi N, Reina R, Rodríguez Lima DR, Silesky Jiménez JI, Ugarte Ubiergo S, Gómez Escobar LG, Díaz Aya DP, Fowler C, Nates JL. Med Intensiva. 2019 Sep 3. pii: S0210-5691(19)30192-5. doi: 10.1016/j.medin.2019.07.013. [Epub ahead of print] English, Spanish. PMID: 31492476
  9. Predictors of Survival in Patients with Advanced Gastrointestinal Malignancies Admitted to the Intensive Care Unit. Ko H, Yan M, Gupta R, Kebbel K, Maiti A, Song J, Nates J, Overman MJ. Oncologist. 2019 Apr;24(4):483-490. doi: 10.1634/theoncologist.2018-0328. Epub 2018 Dec 5. PMID: 30518614
  10. Variability in triage practices for critically ill cancer patients: A randomized controlled trial. Rathi NK, Haque SA, Morales F, Kaul B, Ramirez R, Ovu S, Feng L, Dong W, Price KJ, Ugarte S, Raimondi N, Quintero A, Cardenas YR, Nates JL; LACCTIN and ONCCC-R-NET groups. J Crit Care. 2019 Oct;53:18-24. doi: 10.1016/j.jcrc.2019.05.012. Epub 2019 May 29. PMID: 31174172
  11. Management of the Critically Ill Adult Chimeric Antigen Receptor-T Cell Therapy Patient: A Critical Care Perspective. Gutierrez C, McEvoy C, Mead E, Stephens RS, Munshi L, Detsky ME, Pastores SM, Nates JL. Crit Care Med. 2018 Sep;46(9):1402-1410. doi: 10.1097/CCM.0000000000003258. PMID: 29939878
  12. Sepsis and Acute Myeloid Leukemia: A Population-Level Study of Comparative Outcomes of Patients Discharged From Texas Hospitals. Malik IA, Cardenas-Turanzas M, Gaeta S, Borthakur G, Price K, Cortes J, Nates JL. Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):e27-e32. doi: 10.1016/j.clml.2017.07.009. Epub 2017 Jul 25. PMID: 28844403
  13. Prognostic Index for Critically Ill Allogeneic Transplantation Patients. Bayraktar UD, Milton DR, Shpall EJ, Rondon G, Price KJ, Champlin RE, Nates JL. Biol Blood Marrow Transplant. 2017 Jun;23(6):991-996. doi: 10.1016/j.bbmt.2017.03.003. Epub 2017 Mar 3. PMID: 28263919
  14. Predictors of survival in patients with sarcoma admitted to the intensive care unit. Gupta R, Heshami N, Jay C, Ramesh N, Song J, Lei X, Rose EJ, Carter K, Araujo DM, Benjamin RS, Patel S, Nates JL, Ravi V. Clin Sarcoma Res. 2016 Jul 19;6:12. doi: 10.1186/s13569-016-0051-5. eCollection 2016. PMID: 27437097
  15. Validation Study of Energy Requirements in Critically Ill, Obese Cancer Patients. Tajchman SK, Tucker AM, Cardenas-Turanzas M, Nates JL. JPEN J Parenter Enteral Nutr. 2016 Aug;40(6):806-13. doi: 10.1177/0148607115574289. Epub 2015 Mar 9. PMID: 25754439
  16. Cervical hematoma following an endocrine surgical procedure: The MD Anderson experience. Christakis IA, Potylchansky E, Silva AM, Nates JP, Prieto PA, Graham PH, Grubbs EG, Lee JE, Perrier ND. Surgery. 2016 Aug;160(2):377-83. doi: 10.1016/j.surg.2016.02.024. Epub 2016 Apr 7. PMID: 27063343
  17. ICU Admission, Discharge, and Triage Guidelines: A Framework to Enhance Clinical Operations, Development of Institutional Policies, and Further Research. Nates JL, Nunnally M, Kleinpell R, Blosser S, Goldner J, Birriel B, Fowler CS, Byrum D, Miles WS, Bailey H, Sprung CL. Crit Care Med. 2016 Aug;44(8):1553-602. doi: 10.1097/CCM.0000000000001856. PMID: 27428118
  18. Intensive care outcomes in adult hematopoietic stem cell transplantation patients. Bayraktar UD, Nates JL. World J Clin Oncol. 2016 Feb 10;7(1):98-105. doi: 10.5306/wjco.v7.i1.98. Review. PMID: 26862493
  19. Two Decades of ICU Utilization and Hospital Outcomes in a Comprehensive Cancer Center. Wallace SK, Rathi NK, Waller DK, Ensor JE Jr, Haque SA, Price KJ, Piller LB, Tilley BC, Nates JL. Crit Care Med. 2016 May;44(5):926-33. doi: 10.1097/CCM.0000000000001568. PMID: 26765498
  20. Preoperative anemia, blood transfusion, and neutrophil-to-lymphocyte ratio in patients with stage i non-small cell lung cancer. Cata JP, Gutierrez C, Mehran RJ, Rice D, Nates J, Feng L, Rodriguez-Restrepo A, Martinez F, Mena G, Gottumukkala V. Cancer Cell Microenviron. 2016;3(1):e1116. PMID: 26949721
  21. Out-of-Hospital ICU Transfers to an Oncological Referral Center: Characteristics, Resource Utilization, and Patient Outcomes. Gutierrez C, Cárdenas YR, Bratcher K, Melancon J, Myers J, Campbell JY, Feng L, Price KJ, Nates JL. J Intensive Care Med. 2019 Jan;34(1):55-61. doi: 10.1177/0885066616686536. Epub 2016 Dec 29. PMID: 28030995
  22. Place of Death among Hospitalized Patients with Cancer at the End of Life. Wallace SK, Waller DK, Tilley BC, Piller LB, Price KJ, Rathi N, Haque S, Nates JL. J Palliat Med. 2015 Aug;18(8):667-76. doi: 10.1089/jpm.2014.0389. Epub 2015 Apr 30. PMID: 25927588
  23. Low-, medium- and high-dose steroids with or without aminocaproic acid in adult hematopoietic SCT patients with diffuse alveolar hemorrhage. Rathi NK, Tanner AR, Dinh A, Dong W, Feng L, Ensor J, Wallace SK, Haque SA, Rondon G, Price KJ, Popat U, Nates JL. Bone Marrow Transplant. 2015 Mar;50(3):420-6. doi: 10.1038/bmt.2014.287. Epub 2014 Dec 22. PMID: 25531284
  24. Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit. Bayraktar UD, Shpall EJ, Liu P, Ciurea SO, Rondon G, de Lima M, Cardenas-Turanzas M, Price KJ, Champlin RE, Nates JL. J Clin Oncol. 2013 Nov 20;31(33):4207-14. doi: 10.1200/JCO.2013.50.5867. Epub 2013 Oct 14. PMID: 24127454
  25. Prognostic indicators of mortality of mechanically ventilated patients with acute leukemia in a comprehensive cancer center. Price KJ, Cardenas-Turanzas M, Lin H, Roden L, Nigam R, Nates JL. Minerva Anestesiol. 2013 Feb;79(2):147-55. Epub 2012 Oct 2. PMID: 23032926
  26. Outcome analyses after the first admission to an intensive care unit in patients with advanced cancer referred to a phase I clinical trials program. Fu S, Hong DS, Naing A, Wheler J, Falchook G, Wen S, Howard A, Barber D, Nates J, Price K, Kurzrock R. J Clin Oncol. 2011 Sep 10;29(26):3547-52. doi: 10.1200/JCO.2010.33.3823. Epub 2011 Aug 15. PMID: 21844494


Ongoing Studies
​

  • Early Metabolic Resuscitation (EMR) for Septic Shock
  • Hematologic Septic Shock
  • ​Solid Tumors Septic Shock

ONCCC-R-NET
Investigators:
Joseph L Nates, MD
Diego H de Villalobos, MD